Login / Signup

A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.

Sheng-Yuan YuByung-Kun KimHebo WangJiying ZhouQi WanTingmin YuYajun LianMichal ArkuszewskiLaurent EcochardShihua WenFangfang YinZheng LiWendy SuShuu-Jiun Wang
Published in: The journal of headache and pain (2022)
NCT03867201.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • clinical trial
  • newly diagnosed
  • double blind
  • prognostic factors
  • peritoneal dialysis
  • open label
  • study protocol